University of Connecticut University of UC Title Fallback Connecticut

sci cafe

Science Cafe on Youth Substance Abuse and Depression

You are invited to join CICATS for a Science Cafe titlted Youth Substance Use Disorders with Co-occurring Depression: The Nature of the Association and Implications for Treatment on February 20, 2018 in West Hartford, CT. For full details click here

Pre-K

Pre-K Scholar Career Development Award Program

CICATS Pre-K Career Development Award Program is now accepting applications. This program is designed to equip junior faculty with the knowledge and competencies to effectively apply for a NIH Research Career Development Award (K award) as well as to become leaders in clinical and translational science. If you are interested learning more or submitting an application click here.

Deadline: January 31, 2018

kavli

Funding Opportunity

Funded by The Kavli Foundation, CICATS Science Cafés create a social environment for individuals to interact and discuss innovative ideas about translational science and scientific research in general. This Science Cafe funding opportunity is open to UConn Health and UConn Storrs. Read more.

Deadline: Ongoing

Laurencin

Dr. Cato T. Laurencin Receives New Prestigious Appointment

CICATS Chief Executive Officer Dr. Cato Laurencin has been appointed to the new Scientific Advisory Board of The Rady Children’s Institute for Genomic Medicine. Read more.

health equity

Visualize Health Equity

Two UConn M.D. candidates were selected for inclusion in the National Academy of Medicine's permanent online art gallery about health equity. Both pieces are currently featured on our blog. Read more.

Pramod

CIG Directors Lead World’s First Ovarian Cancer Vaccine Trial

Three directors from two of CICATS’ Core Interest Groups: Women’s Cancer Consortium Core Interest Group (CIG) and the Personalized Immunotherapy CIG: Dr. Pramod Srivastava, Dr. Susan Tannenbaum, and Dr. Molly Brewer, are part of the world’s first personalized genomics-driven ovarian cancer vaccine clinical trial. Read more.